PATRICK GREGORY S (VP, Chief Financial Officer) sold 10.1% of their position (5K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $125.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/10/2020ACC: 0001104659-20-123596
Officer· VP, Chief Financial Officer
Since Jul 2018
-5K
Net shares
Net seller
$125.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
$12.98
Trade value
$64.90K
% of position
11.2%
11/9/2020
44.46K→49.46K
Common Stock
Direct
Shares
−5K
Price / share
$25.00
Trade value
$125K
% of position
10.1%
11/9/2020
49.46K→44.46K
Total
Net shares
+0.00
Net value
-$60.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/9/2020 | M · Option Exercise | +5K | $12.98 | $64.90K | 11.2% | 44.46K | 49.46K |
| Common Stock Direct | 11/9/2020 | S · Sale | −5K | $25.00 | $125K | 10.1% | 49.46K | 44.46K |
| Total | +0.00 | -$60.10K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
12.98
Held after
10K
Exercisable
—
11/9/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock5K shares | 11/9/2020 | M · Option Exercise | −5K | 12.98 | — | 10K |